Printer Friendly
The Free Library
14,632,679 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Top Biotech Industry Executives, Analysts, Investors, VCs and Bankers To Gather at BIO's CEO & Investor Conference.


Attendees to Explore Investment Landscape, Industry Challenges and Opportunities

BIO:
What:   <
The BIO CEO & Investor Forum 2007
        <

Where:  <
The Waldorf=Astoria Hotel, New York City
        <

When:   <
February 12-14, 2007
        <

About:  <
Now in its ninth year, the BIO CEO & Investor Conference
        <
will focus on the central theme "Investing in Biotechnology:
        <
The value, The Risks, The Rewards." Senior biotechnology
        <
executives, institutional investors, industry analysts,
        <
venture capitalists, investment bankers and other industry
        <
executives are encouraged to participate in the countless
        <
opportunities to shape the future investment landscape of the
        <
biotechnology industry presented in this forum, including:


* 2,660 possible One-On-One meetings

* 11 concurrent tracks highlighting biotechnology investments and opportunities

* Opening plenary session Plenary session is a term often used in s to define the part of the conference when all members of all parties are in attendance.

These sessions may contain a broad range of content from Keynotes to Panel Discussions and are not necessarily related to a specific style of delivery.
 addressing the recent changes in Congress and its effects on the industry

* Therapeutic Workshops with panels addressing exciting new therapeutic topics such as: Parkinson's Disease Parkinson's disease or Parkinsonism, degenerative brain disorder first described by the English surgeon James Parkinson in 1817. When there is no known cause, the disease usually appears after age 40 and is referred to as Parkinson's disease. , Prostate Cancer prostate cancer, cancer originating in the prostate gland. Prostate cancer is the leading malignancy in men in the United States and is second only to lung cancer as a cause of cancer death in men. , Sleep Disorders Sleep Disorders Definition

Sleep disorders are a group of syndromes characterized by disturbance in the patient's amount of sleep, quality or timing of sleep, or in behaviors or physiological conditions associated with sleep.
 and Aging.

* Over 1,000 investors in attendance

A full program listing can be found at: http://ceo.bio.org/opencms/ceo/2007/index.jsp

Only reporters and editors working full-time for print or broadcast news organizations may register onsite with valid media credentials CREDENTIALS, international law. The instruments which authorize and establish a public minister in his character with the state or prince to whom they are addressed. If the state or prince receive the minister, he can be received only in the quality attributed to him in his credentials. .

About BIO

BIO represents more than 1,100 biotechnology companies Top 100 Biotechnology Companies
The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies.
, academic institutions, state biotechnology centers and related organizations across the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area.  and 31 other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology Environmental biotechnology is when biotechnology is applied to and used to study the natural environment. Environmental biotechnology could also imply that one try to harness biological process for commercial uses and exploitation.  products. BIO also produces the annual BIO International Convention, the world's largest biotechnology conference and exhibition.

Upcoming BIO Events
--  BIO CEO & Investor Conference

    Feb. 12-14, 2007

    New York City



--  2007 World Congress on Industrial Biotechnology and Bioprocessing

    March 21-24, 2007

    Orlando, FL



--  BIO International Convention

    May 6-9, 2007

    Boston, MA



--  BIO VentureForum-East 2007

    June 18-20, 2007

    Montreal, Canada
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Feb 9, 2007
Words:282
Previous Article:Fitch Downgrades ARAMARK's IDR to 'B' & Rates Sr. Notes 'B-/RR5'.
Next Article:GE Board of Directors Authorizes Regular Quarterly Dividend.
Topics:



Related Articles
Tech Startups Break Venture Capital Habit.(Brief Article)
Venture Firm Seizing Upon Wide-Open Biotech Sector.(Brief Article)(Statistical Data Included)
Mann Slates Biotech IPO By Year End.(entrepreneur Alfred Mann)(Brief Article)(Statistical Data Included)
Yield: people * technology * companies * issues.(article introduces new supplement that explores the food, fiber and agriculture industries)(Industry...
Introductions are in order.
Trade mission builds on life sciences industry.(Provincial Update)
Turnaround appears on horizon for L.A. biotech funding.
Local biotech company goes public with reverse merger.(Cougar Biotechnology Inc.)
MultiCell Technologies CEO to be Featured Presenter at BIO InvestorForum 2006 Biotechnology Conference.
Top Industry And Financial Leaders to Explore Key Business Issues Impacting The Biotech Industry At BIO's CEO & Investor Conference.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles